PERSPECTA

News from every angle

Back to headlines

Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out - Reuters

Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out  Reuters

23 Feb, 11:43 — 23 Feb, 11:43
PostShare